Tailored exercise may ease symptoms of rare blood cancer
NCT ID NCT07384039
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study tests whether a 3-month personalized exercise program can improve quality of life, fitness, and symptoms in people with myeloproliferative neoplasms (MPN), a group of rare blood cancers. About 80 participants will be randomly assigned to either start the exercise program right away or wait 3 months before starting. Researchers will measure changes in exercise capacity, muscle strength, daily activity, and symptom burden to see if the program helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOPROLIFERATIVE NEOPLASMS (MPN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hannover Medical School
NOT_YET_RECRUITINGHanover, Lower Saxony, 30625, Germany
-
Hannover Medical School
RECRUITINGHanover, Lower Saxony, 30625, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.